Rhythm Pharmaceuticals buy Morgan Stanley
Start price
07.03.25
/
50%
€46.80
Target price
07.03.26
€66.38
Performance (%)
67.74%
Price
27.02.26
€81.50
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley for Rhythm Pharmaceuticals has seen massive gains of 67.74%. This prediction currently runs until 07.03.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | -4.118% | -4.118% |
| iShares Core DAX® | -0.383% | 1.093% |
| iShares Nasdaq 100 | -0.411% | -1.973% |
| iShares Nikkei 225® | 1.838% | 10.261% |
| iShares S&P 500 | -0.712% | 0.445% |
Comments by Morgan_Stanley for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $72.00 price target on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Morgan_Stanley for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€100.00
11.12.25
11.12.25
-
11.12.26
11.12.26
-21.50%
27.02.26
27.02.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€95.00
16.10.25
16.10.25
€110.50
16.10.26
16.10.26
-17.37%
27.02.26
27.02.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€83.00
25.09.25
25.09.25
-
25.09.26
25.09.26
-1.81%
27.02.26
27.02.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€74.50
11.07.25
11.07.25
€81.37
11.07.26
11.07.26
5.37%
27.02.26
27.02.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€42.40
19.12.23
19.12.23
€50.16
19.12.24
19.12.24
30.90%
20.12.24
20.12.24